Compare PNTG & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PNTG | QDEL |
|---|---|---|
| Founded | 2019 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | 2019 | 2022 |
| Metric | PNTG | QDEL |
|---|---|---|
| Price | $39.65 | $17.53 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 4 |
| Target Price | ★ $37.00 | $28.25 |
| AVG Volume (30 Days) | 339.6K | ★ 1.7M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 20.00 | ★ 45.35 |
| EPS | ★ 0.24 | N/A |
| Revenue | $947,705,000.00 | ★ $2,730,200,000.00 |
| Revenue This Year | $24.72 | $3.51 |
| Revenue Next Year | $7.61 | $3.86 |
| P/E Ratio | $165.63 | ★ N/A |
| Revenue Growth | ★ 36.31 | N/A |
| 52 Week Low | $21.74 | $9.92 |
| 52 Week High | $41.67 | $35.58 |
| Indicator | PNTG | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 68.36 | 60.47 |
| Support Level | $28.25 | $10.87 |
| Resistance Level | N/A | $17.78 |
| Average True Range (ATR) | 1.59 | 1.29 |
| MACD | 0.28 | 0.12 |
| Stochastic Oscillator | 73.42 | 71.48 |
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. It operates in two segments; home health and hospice services and senior living services. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.